Benton Andrew 4
4 · Ensysce Biosciences, Inc. · Filed Feb 4, 2022
Insider Transaction Report
Form 4
Benton Andrew
Director
Transactions
- Award
Stock Option
2022-02-04+20,000→ 20,000 totalExercise: $3.13Exp: 2032-02-04→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]On February 4, 2022, Mr. Benton was granted an option (the "Stock Option") to purchase 20,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.01 per share, with an exercise price of $3.13, under the that certain Ensysce Biosciences, Inc. Amended and Restated 2021 Omnibus Incentive Plan. The Stock Option is scheduled to vest on the date of the Company's annual stockholder meeting in 2022.